AORT
Artivion, Inc. NYSE Listed Feb 12, 1993$21.19
-0.05%
vs $21.20
Mkt Cap $999.4M
52w Low $20.10
4.0% of range
52w High $47.63
50d MA $28.14
200d MA $38.34
P/E (TTM)
100.9x
EV/EBITDA
24.1x
P/B
2.1x
Debt/Equity
0.7x
ROE
2.2%
P/FCF
-1097.0x
RSI (14)
42.10
ATR (14)
$0.99
Beta
1.62
50d MA
$28.14
200d MA
$38.34
Avg Volume
971.8K
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita Open Plus and E-vita Open Neo. It also provides E-xtra design engineering systems for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-nya, a thoracic stent graft system for the minimally invasive repair of lesions of the descending aorta; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, an abdominal aortic aneurysms stent graft system. In addition, the company offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; cardiac laser therapy products for angina treatment; CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; On-X prosthetic aortic and mitral heart valves and the On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as pyrolytic carbon coating services to medical device manufacturers. It serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion Inc. in January 2022. The company was founded in 1984 and is headquartered in Kennesaw, Georgia.
1655 Roberts Boulevard N.W. · Kennesaw, GA 30144 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | AMC | 0.06 | 0.08 | +33.3% | 35.42 | -22.9% | -28.3% | -6.3% | -3.0% | -3.8% | +3.1% | — |
| Feb 12, 2026 | AMC | 0.14 | 0.17 | +21.4% | 40.65 | -4.2% | -10.0% | -0.3% | +2.8% | +1.3% | +0.9% | — |
| Nov 6, 2025 | AMC | 0.14 | 0.16 | +14.3% | 47.50 | -1.8% | -5.5% | +0.2% | +4.2% | +1.6% | -4.3% | — |
| Aug 7, 2025 | AMC | 0.11 | 0.24 | +118.2% | 32.70 | +17.7% | +25.2% | +4.9% | +2.1% | -0.3% | -1.8% | — |
| May 5, 2025 | AMC | 0.12 | 0.06 | -50.0% | 23.77 | +5.0% | +15.4% | +3.5% | +0.5% | +1.3% | -0.5% | — |
| Feb 24, 2025 | AMC | 0.12 | -0.39 | -425.0% | 27.85 | -7.4% | -8.2% | -0.5% | -0.2% | +0.2% | -1.1% | — |
| Nov 7, 2024 | AMC | 0.10 | 0.12 | +20.6% | 28.98 | +1.8% | -0.9% | +0.6% | -3.9% | -1.9% | -0.8% | — |
| Aug 8, 2024 | AMC | -0.49 | 0.07 | +114.3% | 25.33 | +2.4% | -1.9% | +1.1% | -0.2% | -2.3% | +3.0% | — |
| May 6, 2024 | AMC | 0.02 | 0.06 | +170.3% | 21.07 | +8.7% | +12.8% | -2.0% | +0.4% | +0.6% | -1.4% | — |
| Feb 15, 2024 | AMC | -0.13 | 0.11 | +184.6% | 18.04 | +7.6% | +4.3% | -0.6% | +4.7% | +0.7% | +2.8% | — |
| Nov 2, 2023 | AMC | -0.01 | 0.02 | +314.4% | 12.95 | +5.0% | +9.9% | -2.2% | -0.9% | -0.2% | -3.0% | — |
| Aug 3, 2023 | AMC | 0.06 | 0.06 | +7.9% | 16.79 | +2.0% | -1.6% | +3.9% | -2.2% | -1.4% | +0.1% | — |
| May 4, 2023 | AMC | -0.07 | 0.02 | +127.6% | 13.35 | +12.2% | +13.8% | -3.8% | +0.6% | +0.7% | -0.5% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 10 | Ladenburg Thalmann | Upgrade | Neutral → Buy | — | $36.51 | $37.81 | +3.6% | +3.1% | +2.5% | -1.6% | -1.3% | -1.9% |
| Apr 7 | Needham | Maintains | Buy → Buy | — | $33.45 | $34.70 | +3.7% | +5.3% | +2.4% | +1.2% | +3.1% | +2.5% |
| Feb 13 | Canaccord Genuity | Maintains | Buy → Buy | — | $40.65 | $38.95 | -4.2% | -10.0% | -0.3% | +2.8% | +1.3% | +0.9% |
| Feb 2 | Needham | Maintains | Buy → Buy | — | $40.77 | $40.58 | -0.5% | +1.1% | +1.0% | -3.7% | -1.5% | +0.3% |
| Nov 7 | Needham | Maintains | Buy → Buy | — | $47.50 | $46.63 | -1.8% | -5.5% | +0.2% | +4.2% | +1.6% | -4.3% |
| Nov 7 | Canaccord Genuity | Maintains | Buy → Buy | — | $47.50 | $46.63 | -1.8% | -5.5% | +0.2% | +4.2% | +1.6% | -4.3% |
| Nov 7 | Citizens | Maintains | Market Outperform → Market Outperform | — | $47.50 | $46.63 | -1.8% | -5.5% | +0.2% | +4.2% | +1.6% | -4.3% |
| Oct 10 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $40.35 | $40.68 | +0.8% | -0.4% | +1.1% | +1.0% | +1.2% | +0.0% |
| Sep 29 | Stifel | Maintains | Buy → Buy | — | $41.06 | $42.26 | +2.9% | +2.4% | +0.7% | -2.9% | -1.3% | +1.1% |
| Sep 29 | Canaccord Genuity | Maintains | Buy → Buy | — | $41.06 | $42.26 | +2.9% | +2.4% | +0.7% | -2.9% | -1.3% | +1.1% |
| Aug 22 | Needham | Maintains | Buy → Buy | — | $43.14 | $43.46 | +0.7% | +3.9% | -2.8% | +1.1% | -0.7% | +0.2% |
| Aug 13 | Ladenburg Thalmann | Downgrade | Buy → Neutral | — | $43.85 | $43.33 | -1.2% | -0.3% | -1.8% | -0.3% | +0.1% | -1.9% |
| Aug 8 | Needham | Maintains | Buy → Buy | — | $32.70 | $38.49 | +17.7% | +25.2% | +4.9% | +2.1% | -0.3% | -1.8% |
| Aug 8 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $32.70 | $38.49 | +17.7% | +25.2% | +4.9% | +2.1% | -0.3% | -1.8% |
| Aug 8 | Stifel | Maintains | Buy → Buy | — | $32.70 | $38.49 | +17.7% | +25.2% | +4.9% | +2.1% | -0.3% | -1.8% |
| Aug 8 | Canaccord Genuity | Maintains | Buy → Buy | — | $32.70 | $38.49 | +17.7% | +25.2% | +4.9% | +2.1% | -0.3% | -1.8% |
| May 6 | Needham | Maintains | Buy → Buy | — | $23.77 | $24.96 | +5.0% | +15.4% | +3.5% | +0.5% | +1.3% | -0.5% |
| May 6 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $23.77 | $24.96 | +5.0% | +15.4% | +3.5% | +0.5% | +1.3% | -0.5% |
| Feb 25 | Needham | Maintains | Buy → Buy | — | $27.85 | $25.80 | -7.4% | -8.2% | -0.5% | -0.2% | +0.2% | -1.1% |
| Feb 25 | Stifel | Maintains | Buy → Buy | — | $27.85 | $25.80 | -7.4% | -8.2% | -0.5% | -0.2% | +0.2% | -1.1% |
| Feb 25 | Citizens Capital Markets | Maintains | Market Outperform → Market Outperform | — | $27.85 | $25.80 | -7.4% | -8.2% | -0.5% | -0.2% | +0.2% | -1.1% |
| Jan 28 | Needham | Maintains | Buy → Buy | — | $30.64 | $30.58 | -0.2% | +1.3% | +0.6% | +0.5% | -1.3% | -1.2% |
| Dec 10 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $29.00 | $28.79 | -0.7% | +2.9% | +0.3% | -1.4% | -1.9% | +0.1% |
| Dec 9 | Needham | Maintains | Buy → Buy | — | $29.66 | $29.67 | +0.0% | -2.2% | +2.9% | +0.3% | -1.4% | -1.9% |
| Nov 8 | Oppenheimer | Maintains | Outperform → Outperform | — | $28.98 | $29.50 | +1.8% | -0.9% | +0.6% | -3.9% | -1.9% | -0.8% |
| Sep 27 | Needham | Maintains | Buy → Buy | — | $25.76 | $25.90 | +0.5% | +4.2% | -0.9% | -1.3% | +0.3% | -1.6% |
| Sep 13 | Stifel | Maintains | Buy → Buy | — | $24.75 | $25.52 | +3.1% | +2.0% | +0.5% | -0.6% | -1.0% | +0.7% |
| Aug 9 | Stifel | Maintains | Buy → Buy | — | $25.33 | $25.94 | +2.4% | -1.9% | +1.1% | -0.2% | -2.3% | +3.0% |
| Aug 9 | Needham | Maintains | Buy → Buy | — | $25.33 | $25.94 | +2.4% | -1.9% | +1.1% | -0.2% | -2.3% | +3.0% |
| Aug 9 | Oppenheimer | Maintains | Outperform → Outperform | — | $25.33 | $25.94 | +2.4% | -1.9% | +1.1% | -0.2% | -2.3% | +3.0% |
| Jul 2 | Lake Street | Maintains | Buy → Buy | — | $25.45 | $25.62 | +0.7% | +0.8% | +0.8% | -2.2% | +1.5% | +0.8% |
| May 7 | Stifel | Maintains | Buy → Buy | — | $21.07 | $22.90 | +8.7% | +12.8% | -2.0% | +0.4% | +0.6% | -1.4% |
| May 7 | Needham | Maintains | Buy → Buy | — | $21.07 | $22.90 | +8.7% | +12.8% | -2.0% | +0.4% | +0.6% | -1.4% |
| Apr 8 | Needham | Maintains | Buy → Buy | — | $21.34 | $21.32 | -0.1% | +1.4% | +0.0% | -0.8% | -0.7% | -4.0% |
| Feb 16 | Stifel | Maintains | Buy → Buy | — | $18.04 | $19.41 | +7.6% | +4.3% | -0.6% | +4.7% | +0.7% | +2.8% |
| Feb 16 | Needham | Maintains | Buy → Buy | — | $18.04 | $19.41 | +7.6% | +4.3% | -0.6% | +4.7% | +0.7% | +2.8% |
| Dec 7 | Needham | Maintains | Buy → Buy | — | $17.83 | $17.82 | -0.1% | +1.0% | +0.4% | -0.2% | +2.4% | -0.1% |
| Nov 3 | Needham | Maintains | Buy → Buy | — | $12.95 | $13.60 | +5.0% | +9.9% | -2.2% | -0.9% | -0.2% | -3.0% |
| Aug 4 | Needham | Maintains | Buy → Buy | — | $16.79 | $17.12 | +2.0% | -1.6% | +3.9% | -2.2% | -1.4% | +0.1% |
| May 8 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $15.19 | $15.20 | +0.1% | -3.8% | +0.6% | +0.7% | -0.5% | +0.9% |
| May 5 | Needham | Maintains | Buy → Buy | — | $13.35 | $14.98 | +12.2% | +13.8% | -3.8% | +0.6% | +0.7% | -0.5% |
| Feb 17 | Needham | Maintains | Buy → Buy | — | $13.20 | $15.18 | +15.0% | +5.8% | -5.6% | +2.0% | -0.4% | -3.4% |
| Nov 4 | Needham | Maintains | Buy → Buy | — | $11.40 | $11.17 | -2.0% | -1.9% | +1.4% | -2.7% | -0.4% | +10.1% |
| Oct 11 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $11.35 | $11.29 | -0.5% | -8.3% | -2.8% | +6.4% | -3.2% | +5.6% |
| Sep 26 | Oppenheimer | Maintains | Outperform → Outperform | — | $13.31 | $13.32 | +0.1% | +3.1% | +2.5% | +3.9% | -0.7% | -4.6% |
| Sep 26 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $13.31 | $13.32 | +0.1% | +3.1% | +2.5% | +3.9% | -0.7% | -4.6% |
| Aug 8 | Lake Street | Maintains | Buy → Buy | — | $21.19 | $21.34 | +0.7% | +3.6% | -2.9% | +2.7% | -0.6% | +4.4% |
| Jul 15 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $18.29 | $18.64 | +1.9% | +0.8% | -1.5% | +3.9% | +0.8% | +2.6% |
| May 6 | Needham | Maintains | Buy → Buy | — | $19.16 | $19.55 | +2.0% | -4.3% | -9.9% | -1.8% | -3.0% | -0.1% |
| Mar 3 | Stifel | Maintains | Buy → Buy | — | $20.80 | $21.32 | +2.5% | +1.7% | +2.5% | -1.8% | -4.6% | +2.0% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | GREEN ANDREW MOff | SVP, Regulatory and Quality | Sell | 30,000 | $20.69 | $621K | 60,259 | +1.80% | — |
| Jun 11, 2026 | GREEN ANDREW MOff | SVP, Regulatory and Quality | Sell | 14,001 | $20.71 | $290K | 60,259 | +1.80% | — |
8-K · 8.01
!! High
Artivion, Inc. -- 8-K 8.01: Material Event / Announcement
Artivion completed its acquisition of Endospan on May 18, 2026, by exercising a purchase option established in a 2019 securities agreement, expanding its product portfolio in vascular interventions.
May 18
8-K
Artivion, Inc. -- 8-K Filing
Artivion management cautions investors that actual financial results may substantially diverge from current projections due to various uncertainties detailed in forward-looking statement disclaimers.
Feb 12
Institutional (13F) — Top 0
All ↗
No 13F holders found.
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$999.4M
Enterprise Value
$1.18B
P/E (TTM)
100.90x
Forward P/E
59.09x
PEG Ratio
-1.25x
P/B
2.14x
P/S
2.26x
P/FCF
-1097.00x
EV/EBITDA
24.06x
Shares Out
47.2M
Financials (TTM)
Revenue
$441.3M
Net Income
$9.8M
EBITDA
$49.2M
Free Cash Flow
-$911K
Op Cash Flow
$38.1M
EPS Basic
$0.22
EPS Diluted
$0.21
EPS Forward
$0.36
Gross Margin
61.3%
Op Margin
6.1%
Net Margin
2.2%
Balance Sheet
Total Assets
$884.8M
Total Liab.
$436.6M
Total Equity
$448.2M
Cash
$64.9M
LT Debt
$249.5M
Book Value/Sh
$9.89
Debt/Equity
0.65x
Current Ratio
2.99
Quick Ratio
2.08
Returns & Growth
ROE
2.2%
ROA
1.1%
ROIC
2.2%
Rev Growth YoY
+13.6%
EPS Growth YoY
+168.8%
Price Returns
2W
-3.2%
1M
-38.1%
3M
-42.4%
6M
-52.4%
12M
-25.0%
Technicals
52W High
$47.63
52W Low
$20.10
50d MA
$28.14
200d MA
$38.34
RSI (14)
42.10
ATR (14)
$0.99
Beta
1.62
Avg Volume
972K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
4
Ex-Div Date
Dec 9, 2015
Analyst Price Targets
Consensus
$52.00
High
$55.00
Low
$50.00
Median
$51.00
Data updated apr 24, 2026 6:18pm
· Source: financialmodelingprep.com